DASGIP – Global Technology Leader in Parallel Bioreactor Systems
Since its founding in 1991, DASGIP AG has established itself as a global provider of technologically-superior parallel bioreactor systems and comprehensive bioprocess software solutions. Today, DASGIP boasts fourteen of the world's fifteens largest pharmaceutical companies as customers. Since January 2012 DASGIP is an Eppendorf company.
